Literature DB >> 17666823

Aldose reductase and advanced glycation endproducts inhibitory effect of Phyllostachys nigra.

Sang Hoon Jung1, Jung Min Lee, Hee Ju Lee, Chul Young Kim, Eun Ha Lee, Byung Hun Um.   

Abstract

To evaluate active principles for diabetic complications from the black bamboo leaves, Phyllostachys nigra, eight compounds were isolated and tested for their effects on rat lens aldose reductase and advanced glycation endproducts. As a result, luteolin 6-C-(6''-O-trans-caffeoylglucoside) was found to show a strong aldose reductase and advanced glycation endproducts inhibition. This compound showed antioxidative activity measured in Photochem apparatus. It is concluded, therefore, that luteolin 6-C-(6''-O-trans-caffeoylglucoside) (6), a flavone of this plant, have antioxidative as well as aldose reductase and advanced glycation endproducts inhibitory effects. As a result, this compound could be offered as a leading compound for further study as a new natural products drug for diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666823     DOI: 10.1248/bpb.30.1569

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

1.  Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammation.

Authors:  Dahae Lim; Youngwoo Cho; Woogyeong Kim; Sehee Jeong; Young Pyo Jang; Jinju Kim
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-02

2.  Potential Medicinal Application and Toxicity Evaluation of Extracts from Bamboo Plants.

Authors:  Jun Panee
Journal:  J Med Plant Res       Date:  2015-06-17

3.  Aqueous extract of Bambusae Caulis in Taeniam inhibits PMA-induced tumor cell invasion and pulmonary metastasis: suppression of NF-κB activation through ROS signaling.

Authors:  Aeyung Kim; Minju Im; Nam-Hui Yim; Young Pil Jung; Jin Yeul Ma
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

4.  Bioactivity Focus of α-Cyano-4-hydroxycinnamic acid (CHCA) Leads to Effective Multifunctional Aldose Reductase Inhibitors.

Authors:  Laitao Zhang; Yi-Fang Li; Sheng Yuan; Shijie Zhang; Huanhuan Zheng; Jie Liu; Pinghua Sun; Yijun Gu; Hiroshi Kurihara; Rong-Rong He; Heru Chen
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

5.  Inhibitory Activities of Stauntonia hexaphylla Leaf Constituents on Rat Lens Aldose Reductase and Formation of Advanced Glycation End Products and Antioxidant.

Authors:  Seung Hwan Hwang; Shin Hwa Kwon; Set Byeol Kim; Soon Sung Lim
Journal:  Biomed Res Int       Date:  2017-02-23       Impact factor: 3.411

6.  Evaluation of Aldose Reductase, Protein Glycation, and Antioxidant Inhibitory Activities of Bioactive Flavonoids in Matricaria recutita L. and Their Structure-Activity Relationship.

Authors:  Seung Hwan Hwang; Zhiqiang Wang; Yanymee N Guillen Quispe; Soon Sung Lim; Jae Myung Yu
Journal:  J Diabetes Res       Date:  2018-04-10       Impact factor: 4.011

7.  Inhibitory effects of Colocasia esculenta (L.) Schott constituents on aldose reductase.

Authors:  Hong Mei Li; Seung Hwan Hwang; Beom Goo Kang; Jae Seung Hong; Soon Sung Lim
Journal:  Molecules       Date:  2014-08-27       Impact factor: 4.411

8.  Prevention of Diabetic Complications by Walnut Leaf Extract via Changing Aldose Reductase Activity: An Experiment in Diabetic Rat Tissue.

Authors:  Zahra Abbasi; Gholamali Jelodar; Bita Geramizadeh
Journal:  J Diabetes Res       Date:  2020-08-15       Impact factor: 4.011

9.  Structural Bases for Hesperetin Derivatives: Inhibition of Protein Tyrosine Phosphatase 1B, Kinetics Mechanism and Molecular Docking Study.

Authors:  Md Yousof Ali; Susoma Jannat; Hyun-Ah Jung; Jae-Sue Choi
Journal:  Molecules       Date:  2021-12-08       Impact factor: 4.411

10.  Black Bamboo Rhizome Extract Improves Cognitive Dysfunction by Upregulating the Expression of Hippocampal BDNF and CREB in Rats with Cerebral Ischaemia-Reperfusion Injury.

Authors:  Chuan-An Yi; Yu-Hong Jiang; Ye Wang; Yu-Xian Li; Shi-Chang Cai; Xiu-Yu Wu; Xiang-Shang Hu; Xing-Guang Wan
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-12       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.